Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/74626
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Woisetschlager, M. | - |
dc.contributor.author | Hauben, E. | - |
dc.contributor.author | Roncarolo, M. | - |
dc.date.issued | 2008 | - |
dc.identifier.uri | http://hdl.handle.net/2440/74626 | - |
dc.description | M. Woisetschlager, E. Hauben, M. G. Roncarolo (assignee Novartis institute for Biomedical Research, Inc.). US 2008/0279829 A1 (PCT/EP2006/009406) filed Sep. 27, 2006; published Nov. 13, 2008. | - |
dc.description.abstract | The use of a phenyl-(4-phenyl-pyrimidin-2-yl)-amine for the preparation of a medicament for enhancing immunotolerance in a mammal; and uses, methods, processes and pharmaceutical combinations and compositions comprising such phenyl-(4-phenyl-pyrimidin-2-yl)-amine. | - |
dc.description.statementofresponsibility | Invented by Maximilian Woisetschlaeger, Ehud Hauben, Maria Grazia Roncarolo; assigned to Novartis institute for Biomedical Research, Inc. | - |
dc.description.uri | http://www.patentlens.net/patentlens/patent/US_2008_0279829_A1/en/ | - |
dc.language.iso | en | - |
dc.title | Phenyl-(4-Phenyl-Pyrimidin-2-YL)-amines for enhancing immunotolerance | - |
dc.type | Patent | - |
dc.contributor.assignee | Novartis institute for Biomedical Research, Inc. Cambridge | - |
dc.identifier.patent | US 2008/0279829 A1 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Hauben, E. [0000-0002-6062-411X] | - |
Appears in Collections: | Aurora harvest Surgery publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.